On the receiving end V: Patient perceptions of the side effects of cancer chemotherapy in 1993

Abstract

The results suggest a reduction in the severity of some symptoms experienced while receiving chemotherapy and a shift from concerns about physical to psychosocial issues.

Chemotherapy‐induced alopecia and effects on quality of life among women with breast cancer: a literature review

“…Figure 1. Results of the search strategy and reasons for excluding articles In a population of mixed cancer patients where the majority had advanced cancer, three articles used the same methodology [16,22,30] to determine which chemotherapy side effects patients had experienced and their relative importance to the patient. Alopecia ranked 3rd in 1983 and 2nd in 2002 [16,30].…”

Palonosetron versus ondansetron for prevention of chemotherapy-induced nausea and vomiting in paediatric patients with cancer receiving moderately or highly emetogenic chemotherapy: a randomised, phase 3, double-blind, double-dummy, non-inferiority study

“…[1][2][3] Adult patients in whom CINV is left uncontrolled experience a severe deterioration in their quality of life and may experience malnourishment, anxiety, and depression. Fear of CINV is sufficient for many patients to postpone or even refuse potentially life-saving treatment.…”

Discordance between physicians' estimations and breast cancer patients' self-assessment of side-effects of chemotherapy: an issue for quality of care

“…Oncologists' attention has, however, been mainly focused on toxicity of chemotherapy and on some of its most noticeable associated side-effects (hair loss, nausea and vomiting) (Coates et al, 1983;Griffin et al, 1996;Morrow, 1996).…”

“…In recent years, there have been more systematic attempts to measure the impact of side-effects on patients' well-being and quality of life during chemotherapy treatments by taking into account patients' subjective point of view (Coates et al, 1983(Coates et al, , 1987Knobf, 1986; Byrne, 1992;Payne, 1992;Griffin et al, 1996;Swain et al, 1996). However, it is obvious that such approaches have not yet been fully integrated in day-to-day clinical practice in oncology (Waitzkin, 1984;Sutherland et al, 1989).…”